Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRSP | AMGN | GILD | VRTX | BIIB |
| Company | Crispr Therapeutics Ag | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 54.21 | 265.72 | 65.50 | 393.52 | 201.22 |
| High | 54.94 | 271.68 | 66.35 | 399.68 | 210.83 |
| Low | 52.81 | 265.72 | 64.63 | 393.49 | 199.10 |
| Last | 53.91 | 269.98 | 65.42 | 397.48 | 208.90 |
| Change | +0.18 | +0.60 | +0.15 | -0.22 | +6.44 |
| % Change | +0.34% | +0.22% | +0.23% | -0.06% | +3.18% |
| Volume | 1,352,600 | 2,436,900 | 12,380,800 | 682,400 | 1,893,800 |
| 20-Day Average Volume | 1,300,905 | 2,156,940 | 7,062,310 | 943,625 | 1,280,090 |
| Previous Close | 53.73 | 269.38 | 65.27 | 397.70 | 202.46 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 59.96 | 269.99 | 68.29 | 401.28 | 201.13 |
| 20-Day Raw Stochastic | 7.42% | 40.03% | 9.20% | 21.25% | 74.13% |
| 20-Day Relative Strength | 31.16% | 45.47% | 29.21% | 42.53% | 49.77% |
| Weighted Alpha | -14.93 | +9.45 | -23.49 | +14.78 | -31.63 |
| Today's Opinion | 24% Sell | 72% Sell | 100% Sell | 8% Buy | 88% Sell |
| Previous Opinion | 24% Sell | 72% Sell | 100% Sell | 8% Buy | 88% Sell |
| Last Month's Opinion | 56% Buy | 40% Buy | 88% Sell | 56% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.07% since 04/19/24 | +0.39% since 04/19/24 | -2.01% since 04/19/24 | +0.81% since 04/19/24 | +7.47% since 04/19/24 |
| Low | 52.75 on 04/25/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 393.00 on 04/25/24 | 192.75 on 04/23/24 |
| High | 58.67 on 04/23/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 406.86 on 04/23/24 | 210.83 on 04/26/24 |
| 1-Month | |||||
| %Chg | -24.04% since 03/26/24 | -4.18% since 03/26/24 | -9.65% since 03/26/24 | -5.01% since 03/26/24 | -1.47% since 03/26/24 |
| Low | 52.75 on 04/25/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 71.54 on 03/27/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 | 217.57 on 03/28/24 |
| 3-Month | |||||
| %Chg | -11.64% since 01/26/24 | -13.40% since 01/26/24 | -17.73% since 01/26/24 | -7.60% since 01/26/24 | -14.67% since 01/26/24 |
| Low | 52.75 on 04/25/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 91.10 on 02/22/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 448.40 on 01/30/24 | 251.99 on 01/31/24 |
| 6-Month | |||||
| %Chg | +37.84% since 10/26/23 | +0.10% since 10/26/23 | -16.66% since 10/26/23 | +10.02% since 10/26/23 | -13.35% since 10/26/23 |
| Low | 38.16 on 10/30/23 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 341.90 on 11/16/23 | 189.44 on 04/19/24 |
| High | 91.10 on 02/22/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,560,764 | 144,488,960 | 81,266,176 | 102,789,152 | 29,429,788 |
| Shares Outstanding, K | 84,883 | 536,376 | 1,245,077 | 258,459 | 145,361 |
| Annual Sales | 371,210,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -153,610,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 201,210,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 2,386,300,000 |
| Last Quarter Net Income | 89,350,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 249,700,000 |
| 60-Month Beta | 1.76 | 0.58 | 0.19 | 0.35 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.10 on 02/21/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 4.20 on 02/05/24 | 3.67 on 04/24/24 |
| Latest Earnings Date | 05/13/24 | 05/02/24 | 04/25/24 | 05/06/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.64 | 9.98 | 29.82 | 13.47 |